Revisiting COVID-19 Screening after PHE Ends

Revisiting COVID-19 Screening after PHE Ends

It’s time to revisit screening for COVID-19.

Some of you may recall that I recently pointed out that there is no screening during a pandemic. Now that the federal public health emergency (PHE) has ended, how do we code COVID-19 testing? For more official guidance than me, check out the American Hospital Association (AHA)/American Health Information Management Association (AHA/AHIMA) FAQs at https://www.codingclinicadvisor.com/faqs-icd-10-cm-coding-covid-19. Also, Coding Clinic points out that we continue our current practice until Oct. 1, 2023. This marks the beginning of the new fiscal year after the PHE ended.

Let’s review what “screening” really is. The World Health Organization (WHO) defines screening as “the presumptive identification of unrecognized disease in an apparently healthy, asymptomatic population by means of tests, examinations, or other procedures that can be applied rapidly and easily to the target population.” It is the systematic application of a test to identify asymptomatic individuals at potential risk of a specific disorder to warrant further investigation or direct preventative action. There is no known exposure used as a prompt, and the person being screened does not have an expectation that they are at risk of having contracted a disease.

During an epidemic or pandemic, everyone is suspect. Every contact is a potential exposure. COVID-19 testing was done on symptomatic and asymptomatic patients alike to figure out who was infected and potentially contagious. Z20.822, Contact with and (suspected) exposure to COVID-19 was used as the universal diagnosis for medical necessity for testing during the pandemic.

We have now entered the endemic phase. SARS-CoV-2 is likely to cause intermittent infections forever. It will probably be sporadic, and periodically epidemic. “Epidemic” implies that there will be occasional swells of infections, as well as outbreaks in communities and locales. It may be seasonal, like influenza. We are not yet sure what the long-term endemic phase is going to look like.

But COVID-19 testing will need to be performed when indicated. If there is a suspected or known exposure, the rationale for testing will still be Z20.822, or U07.1, COVID-19, depending on whether the result is negative or positive. Z11.52, Encounter for screening for COVID-19, should be reserved for instances when an asymptomatic population is being routinely tested.

Examples of when Z11.52 would be appropriate would be:

  • If a hospital decides they want to retain preoperative testing across the board. Z01.812, encounter for preprocedural laboratory examination would be first-listed diagnosis, and Z11.52 would be a secondary diagnosis.
  • If a nursing home is testing their staff weekly so they can advertise that they are keeping their patients safe, then non-focused testing can be defined as screening. If the same nursing home tests all patients being admitted to their facility upon entry, that is screening, too.
  • If monthly or quarterly random checks are performed somewhere because a public health department is trying to monitor recrudescence of the virus, again, that is screening.

For all of these scenarios, if a specific individual complains of a sore throat and fatigue, and the provider suspects they may actually have COVID-19, Z11.52 is NOT appropriate. The diagnosis for that symptomatic patient should be Z20.822, along with the symptom codes. If the test is positive, Z20.822 is replaced with U07.1, and the symptoms may potentially be subsumed as being integral to COVID-19.

If all the following criteria are met, Z11.52 is appropriate:

  • No local epidemic;
  • Asymptomatic;
  • Routine, pan-testing of all comers; and
  • No known or suspected exposure.

If there is a sporadic epidemic outbreak, you are back to Z20.822 for any testing, because potential exposure is implied. This is consistent with the Official Guidelines (I.C.21.c.1).

You can read my prior article about this topic at https://icd10monitor.medlearn.com/screening-for-covid-19-when-to-use-z11-59/ but you will need to substitute the correct specific codes. When I wrote that article three years ago, we didn’t have COVID-specific codes yet, so we used the generic codes.

It is said that there are no atheists in foxholes; and there is no screening in pandemics. Now that the pandemic is over, you can start using Z11.52 compliantly after Oct. 1.

Although even I have started venturing out maskless, I am always cognizant that this leaves me at risk of contracting COVID-19 again. Friends, please keep up with your boosters, and stay home if you are sick.

The PHE is over, but COVID-19 isn’t gone.

Programming note: Listen to Dr. Erica Remer live every Tuesday when she cohost Talk Ten Tuesdays with Chuck Buck, 10 Eastern.

Facebook
Twitter
LinkedIn

Erica Remer, MD, FACEP, CCDS, ACPA-C

Erica Remer, MD, FACEP, CCDS, ACPA-C has a unique perspective as a practicing emergency physician for 25 years, with extensive coding, CDI, and ICD-10 expertise. As physician advisor for University Hospitals Health System in Cleveland, Ohio for four years, she trained 2,700 providers in ICD-10, closed hundreds of queries, fought numerous DRG clinical determination and medical necessity denials, and educated CDI specialists and healthcare providers with engaging, case-based presentations. She transitioned to independent consulting in July 2016. Dr. Remer is a member of the ICD10monitor editorial board and is the co-host on the popular Talk Ten Tuesdays weekly, live Internet radio broadcasts.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering Principal Diagnosis: Coding Precision, Medical Necessity, and Quality Impact

Mastering Principal Diagnosis: Coding Precision, Medical Necessity, and Quality Impact

Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.

December 3, 2025

Proactive Denial Management: Data-Driven Strategies to Prevent Revenue Loss

Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.

November 19, 2025
Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.

September 24, 2025

Trending News

Featured Webcasts

Surviving Federal Audits for Inpatient Rehab Facility Services

Surviving Federal Audits for Inpatient Rehab Facility Services

Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.

November 13, 2025
E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.

August 26, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24